Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
1.
J Occup Med Toxicol ; 15: 28, 2020.
Article de Anglais | MEDLINE | ID: mdl-32944060

RÉSUMÉ

BACKGROUND: A two-fold risk increase to develop basal cell carcinoma was seen in outdoor workers exposed to high solar UV radiation compared to controls. However, there is an ongoing discussion whether histopathological subtype, tumor localization and Fitzpatrick phototype may influence the risk estimates. OBJECTIVES: To evaluate the influence of histological subtype, tumor localization and Fitzpatrick phototype on the risk to develop basal cell carcinoma in highly UV-exposed cases and controls compared to those with moderate or low solar UV exposure. METHODS: Six hundred forty-three participants suffering from incident basal cell carcinoma in commonly sun-exposed anatomic sites (capillitium, face, lip, neck, dorsum of the hands, forearms outside, décolleté) of a population-based, case-control, multicenter study performed from 2013 to 2015 in Germany were matched to controls without skin cancer. Multivariate logistic regression analysis was conducted stratified for histological subtype, phototype 1/2 and 3/4. Dose-response curves adjusted for age, age2, sex, phototype and non-occupational UV exposure were calculated. RESULTS: Participants with high versus no (OR 2.08; 95% CI 1.24-3.50; p = 0.006) or versus moderate (OR 2.05; 95% CI 1.15-3.65; p = 0.015) occupational UV exposure showed a more than two-fold significantly increased risk to develop BCC in commonly UV-exposed body sites. Multivariate regression analysis did not show an influence of phototype or histological subtype on risk estimates. The restriction of the analysis to BCC cases in commonly sun-exposed body sites did not influence the risk estimates. The occupational UV dosage leading to a 2-fold increased basal cell carcinoma risk was 6126 standard erythema doses. CONCLUSION: The risk to develop basal cell carcinoma in highly occupationally UV-exposed skin was doubled consistently, independent of histological subtype, tumor localization and Fitzpatrick phototype.

2.
Hautarzt ; 71(8): 580-587, 2020 Aug.
Article de Allemand | MEDLINE | ID: mdl-32533202

RÉSUMÉ

Basal cell carcinoma is the most common type of cancer in Central Europe and has a high medical relevance. Due to its high tendency of recurrence, an important parameter in the planning of therapy is the risk of recurrence. After clinical and histological diagnosis, the majority of tumors are treated surgically, although radiation and topical procedures are also possible therapeutic alternatives in certain constellations. Hedgehog inhibitors, a completely new class of substances, have recently been approved for rare metastatic and locally advanced diseases, thus significantly expanding the range of treatments. This article provides an overview of the current guideline-based diagnosis and therapy of basal cell carcinomas in Germany.


Sujet(s)
Antinéoplasiques/usage thérapeutique , Carcinome basocellulaire/diagnostic , Carcinome basocellulaire/thérapie , Procédures chirurgicales dermatologiques/méthodes , Guides de bonnes pratiques cliniques comme sujet , Tumeurs cutanées/diagnostic , Tumeurs cutanées/thérapie , Carcinome basocellulaire/anatomopathologie , Europe , Allemagne , Protéines Hedgehog , Humains , Récidive tumorale locale/prévention et contrôle , Tumeurs cutanées/anatomopathologie
4.
Med Oncol ; 35(3): 24, 2018 Jan 31.
Article de Anglais | MEDLINE | ID: mdl-29387968

RÉSUMÉ

Despite new therapeutic options, metastatic melanoma remains to be one of the most fatal tumors. With the development of BRAF inhibitors and immune checkpoint inhibitors, overall survival could be prolonged significantly for the first time. Clinical studies implied that even long-term survival is possible with both types of drugs, but predictive markers are so far missing. In this study, we analyzed survival data from patients that received the first-in-class substances vemurafenib and ipilimumab, respectively, during the time period from registration of the drugs until availability of combination treatments. We aimed to evaluate the possibility of long-term survival in a daily life setting and to characterize patients that benefit from these drugs in order to gain insight into predictive attributes. Eighty patients were evaluated who were treated with either vemurafenib (n = 40) or ipilimumab (n = 40), and overall survival was analyzed. Subgroup analysis was performed for patients who were still alive 24 months after induction of therapy (long-term survival). Median overall survival (OS) was 8.0 months for patients treated with vemurafenib and 10.0 months for patients treated with ipilimumab (log-rank P value = 0.689). Long-term survival was achieved in 32.5% of patients (42.3% vemurafenib, 57.7% ipilimumab). Negative predictors of long-term survival in the vemurafenib group were brain and liver metastases, as well as elevated LDH, S100ß and liver enzymes. For ipilimumab, an increase in lymphocytes and eosinophils during course of treatment correlated with long-term survival. Our real-life experience shows that long-term survival is possible with using both therapeutic agents, vemurafenib and ipilimumab. Pattern of metastases and laboratory values might be of interest in decision making for a specific therapeutic approach. Combination of drugs and observational studies in larger patient cohorts are necessary to further validate our findings.


Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Mélanome/mortalité , Tumeurs cutanées/mortalité , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Études de suivi , Humains , Indoles/administration et posologie , Ipilimumab/administration et posologie , Métastase lymphatique , Mâle , Mélanome/traitement médicamenteux , Mélanome/anatomopathologie , Adulte d'âge moyen , Pronostic , Études rétrospectives , Tumeurs cutanées/traitement médicamenteux , Tumeurs cutanées/secondaire , Sulfonamides/administration et posologie , Taux de survie , Vémurafénib , Jeune adulte
5.
Aliment Pharmacol Ther ; 47(1): 55-66, 2018 Jan.
Article de Anglais | MEDLINE | ID: mdl-29052254

RÉSUMÉ

BACKGROUND: Smoking is a strong environmental factor leading to adverse outcomes in Crohn's disease, but a more benign course in ulcerative colitis. Several single nucleotide polymorphisms (SNPs) are associated with smoking quantity and behaviour. AIM: To assess whether smoking-associated SNPs interact with smoking to influence the clinical course of inflammatory bowel diseases. METHODS: Genetic and prospectively obtained clinical data from 1434 Swiss inflammatory bowel disease cohort patients (821 Crohn's disease and 613 ulcerative colitis) were analysed. Six SNPs associated with smoking quantity and behaviour (rs588765, rs1051730, rs1329650, rs4105144, rs6474412 and rs3733829) were combined to form a risk score (range: 0-12) by adding the number of risk alleles. We calculated multivariate models for smoking, risk of surgery, fistula, Crohn's disease location and ulcerative colitis disease extent. RESULTS: In Crohn's disease patients who smoke, the number of surgeries was associated with the genetic risk score. This translates to a predicted 3.5-fold (95% confidence interval: 2.4- to 5.7-fold, P<.0001) higher number of surgical procedures in smokers with 12 risk alleles than individuals with the lowest risk. Patients with a risk score >7 had a significantly shorter time to first intestinal surgery. The genetic risk score did not predict surgery in ulcerative colitis or occurrence of fistulae in Crohn's disease. SNP rs6265 was associated with ileal disease in Crohn's disease (P<.05) and proctitis in ulcerative colitis (P<.05). CONCLUSIONS: SNPs associated with smoking quantity is associated with an increased risk for surgery in Crohn's disease patients who smoke. Our data provide an example of genetics interacting with the environment to influence the disease course of inflammatory bowel disease.


Sujet(s)
Rectocolite hémorragique/chirurgie , Maladie de Crohn/chirurgie , Fumer/épidémiologie , Adulte , Allèles , Études de cohortes , Rectocolite hémorragique/génétique , Maladie de Crohn/génétique , Femelle , Humains , Études longitudinales , Mâle , Adulte d'âge moyen , Polymorphisme de nucléotide simple , Rectite/épidémiologie , Études prospectives , Facteurs de risque , Fumer/effets indésirables , Jeune adulte
6.
Br J Dermatol ; 178(2): 462-472, 2018 02.
Article de Anglais | MEDLINE | ID: mdl-28845516

RÉSUMÉ

BACKGROUND: Squamous cell carcinoma (SCC) is one of the most frequent types of cancer constituting a significant public health burden. Prevention strategies focus on limiting ultraviolet (UV) exposure during leisure time. However, the relative impact of occupational and nonoccupational UV exposure for SCC occurrence is unclear. OBJECTIVES: To investigate the association between occupational and nonoccupational UV exposure for SCC in a multicentre population-based case-control study hypothesizing that high occupational UV exposure increases the risk of SCC. METHODS: Consecutive patients with incident SCC (n = 632) were recruited from a German national dermatology network. Population-based controls (n = 996) without history of skin cancer were recruited from corresponding residents' registration offices and propensity score matched to cases. Lifetime UV exposure, sociodemographic and clinical characteristics were assessed by trained physicians. Occupational and nonoccupational UV exposure doses were estimated by masked investigators using established reference values. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were assessed using conditional logistic regression adjusting for relevant confounders. RESULTS: Total solar UV exposure was significantly associated with increased SCC. The OR for high (> 90th percentile) vs. low (< 40th percentile) and high vs, moderate (40-59th percentile) occupational UV exposure was 1·95 (95% CI 1·19-3·18) and 2·44 (95% CI 1·47-4·06) for SCC. Adjusting for occupational UV exposure, nonoccupational UV exposure was not significantly related to SCC incidence. Dose-response relationships were observed for occupational but not for nonoccupational solar UV exposure. CONCLUSIONS: Solar occupational UV exposure is a major determinant of incident SCC. Our findings indicate that prevention strategies should be further expanded to the occupational setting.


Sujet(s)
Carcinome épidermoïde/étiologie , Tumeurs radio-induites/étiologie , Maladies professionnelles/étiologie , Tumeurs cutanées/étiologie , Rayons ultraviolets/effets indésirables , Adulte , Sujet âgé , Carcinome épidermoïde/épidémiologie , Études cas-témoins , Relation dose-effet des rayonnements , Exposition environnementale/effets indésirables , Femelle , Allemagne/épidémiologie , Humains , Incidence , Mâle , Adulte d'âge moyen , Maladies professionnelles/épidémiologie , Prévalence , Facteurs de risque , Tumeurs cutanées/épidémiologie
8.
Environ Pollut ; 96(2): 155-9, 1997.
Article de Anglais | MEDLINE | ID: mdl-15093414

RÉSUMÉ

Concentrations of airborne lead at Springfield, Missouri, in 1975-1993 have been determined by analysis of particulate material collected on glass-fiber filters during the 19-year period. Nitric acid-soluble lead in 1100 samples collected at a total of 19 monitoring stations was determined by atomic absorption spectroscopy and by differential pulse polarography. Ambient concentrations of airborne lead were found to decrease steadily (by more than 90%) during this period in spite of increases in area population and in automobile traffic. The decrease is significantly correlated with national trends in total emissions of lead to the atmosphere and with US ambient lead levels. Airborne lead from a coal-fired power plant was small compared with that from gasoline burning.

9.
Z Gerontol ; 26(6): 429-35, 1993.
Article de Allemand | MEDLINE | ID: mdl-8147076

RÉSUMÉ

The physiologic changes of the different organs in the elderly result in a diminishing efficiency of the organism and its capability of adapting to new and unusual conditions. Accordingly, physical exercise has to be seen and assessed as prevention of illness in old age. In terms of prevention exercise training is taking the first place within the five different types of physical activities. The other types (coordination, flexibility, strength, rapidity) have to be handled with special conditions, whose importance must be assessed individually. The importance of exercise, physical activities, and sports is increasing especially in preventing coronary artery disease. Metabolic diseases, hypertension, impairment of cerebral functions and also diseases of the musculoskeletal system are improving under suitable physical training. General training exercise training slows down the loss of cardiopulmonal efficiency due to progredient aging. Risks and benefits of physical training have to be deliberated very carefully in considering the state of health of the elderly.


Sujet(s)
Vieillissement/physiologie , Exercice physique/physiologie , Aptitude physique/physiologie , Sujet âgé , Encéphalopathie ischémique/physiopathologie , Encéphalopathie ischémique/prévention et contrôle , Maladies cardiovasculaires/physiopathologie , Maladies cardiovasculaires/prévention et contrôle , Femelle , Humains , Mâle , Maladies ostéomusculaires/physiopathologie , Maladies ostéomusculaires/prévention et contrôle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE